Govindan R - Search Results

1

Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.

Awad MM, Govindan R, Balogh KN, Spigel DR, Garon EB, Bushway ME, Poran A, Sheen JH, Kohler V, Esaulova E, Srouji J, Ramesh S, Vyasamneni R, Karki B, Sciuto TE, Sethi H, Dong JZ, Moles MA, Manson K, Rooney MS, Khondker ZS, DeMario M, Gaynor RB, Srinivasan L. Awad MM, et al. Among authors: govindan r. Cancer Cell. 2022 Sep 12;40(9):1010-1026.e11. doi: 10.1016/j.ccell.2022.08.003. Epub 2022 Aug 25. Cancer Cell. 2022. PMID: 36027916 Free article. Clinical Trial.

2

Practical issues in the management of the patient with small cell lung cancer.

Govindan R, Ihde DC. Govindan R, et al. Chest Surg Clin N Am. 1997 Feb;7(1):167-81. Chest Surg Clin N Am. 1997. PMID: 9001763 Review.

3

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.

Arquette M, Wasserman T, Govindan R, Garfield D, Senzer N, Gillenwater H, Socinski M. Arquette M, et al. Among authors: govindan r. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):59-61. doi: 10.1053/srao.2002.31375. Semin Radiat Oncol. 2002. PMID: 11917286 Clinical Trial.

4

Management of patients with non-small cell lung cancer and poor performance status.

Govindan R. Govindan R. Curr Treat Options Oncol. 2003 Feb;4(1):55-9. doi: 10.1007/s11864-003-0031-x. Curr Treat Options Oncol. 2003. PMID: 12525279 Review.

5

Cetuximab in advanced non-small cell lung cancer.

Govindan R. Govindan R. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4241s-4244s. doi: 10.1158/1078-0432.CCR-040015. Clin Cancer Res. 2004. PMID: 15217966 Review.

6

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

7

Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status.

Govindan R, Garfield DH. Govindan R, et al. Semin Oncol. 2004 Dec;31(6 Suppl 11):27-31. doi: 10.1053/j.seminoncol.2004.10.006. Semin Oncol. 2004. PMID: 15599832 Review.

8

A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.

Govindan R, Lim WT, Arquette MA, Goodner SA, Fears CL, Mortimer JE, Fracasso PM. Govindan R, et al. Oncol Rep. 2006 Jan;15(1):123-7. Oncol Rep. 2006. PMID: 16328044 Free article. Clinical Trial.

9

The role of docetaxel in N2 locally advanced non-small-cell lung cancer.

Pillot G, Govindan R. Pillot G, et al. Among authors: govindan r. Clin Lung Cancer. 2005 Dec;7 Suppl 3:S87-92. doi: 10.3816/clc.2005.s.016. Clin Lung Cancer. 2005. PMID: 16384542 Review.

10

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, Govindan R, You M. Lu Y, et al. Among authors: govindan r. PLoS Med. 2006 Dec;3(12):e467. doi: 10.1371/journal.pmed.0030467. PLoS Med. 2006. PMID: 17194181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

630 results

Search Page